EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Nancy C. Poirier
Glen S. Van Arsdell
John G. Coles
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Poirier, N. C.
Right arrow Articles by Freedom, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Poirier, N. C.
Right arrow Articles by Freedom, R. M.

Eur J Cardiothorac Surg 2000;18:54-61
© 2000 Elsevier Science NL


A novel repair for patients with atrioventricular septal defect requiring reoperation for left atrioventricular valve regurgitation

Nancy C. Poiriera,b, William G. Williamsa,b, Glen S. Van Arsdella,b, John G. Colesa, Jeffrey F. Smallhornc, Ahmed Omranb, Robert M. Freedomc

a Division of Cardiovascular Surgery, Hospital for Sick Children, University of Toronto, 555 University Avenue, Suite 1525, Toronto, ON M5G 1X8, Canada
b Toronto Congenital Cardiac Centre for Adults, Toronto, ON, Canada
c Division for Paediatric Cardiology, Hospital for Sick Children, Toronto, ON M5G 1X8, Canada

Received 8 September 1999; received in revised form 11 January 2000; accepted 22 February 2000.

Corresponding author. Tel.: +1-416-813-6419; fax: +1-416-813-7984
e-mail: bill.williams{at}sickkids.on.ca


    Abstract
 Top
 Abstract
 1. Introduction
 2. Patients and methods...
 3. Results
 4. Discussion
 Appendix A. Conference...
 References
 
Objective: Left atrioventricular valve regurgitation (LAVVR) is the most frequent indication for reoperation following atrioventricular septal defect (AVSD) repair. We estimate from our experience that within 10 years of initial repair, 14% of patients undergoing repair of atrioventricular septal defect (AVSD) require reoperation for this complication. We have developed a novel leaflet augmentation technique for LAVVR which may avoid failure of conventional repair and/or the need for valve replacement. Method: The novel technique consists of insertion of a glutaraldehyde-treated autologous pericardial patch to augment the bridging leaflets of the atrioventricular valve. We describe the outcome of eight patients in whom this technique was used and compared them to 68 other patients with AVSD undergoing reoperation for LAVVR by either conventional repair (n=54) or valve replacement (n=14). Results: There were no early deaths or major complications following patch repair. The mean follow-up is 2.3 years (range 1–8.5 years) during which there were no late deaths. Two patients underwent reintervention at 3.5 and 5 years after patch repair for LAVVR and were successfully rerepaired. Mild residual LAVVR was seen at last echocardiography in six patients and mild to moderate in two. These results compare favorably with the 68 patients who underwent conventional surgery. The 3-year freedom from reoperation was 86% for both repair groups. Dysplastic valve tissue appears to be a major risk factor for failure of conventional repair or for valve replacement. Failure of conventional valve repair led to valve replacement in six of seven patients. Conclusions: For patients with late LAVVR after AVSD repair, pericardial leaflet augmentation is durable and may avoid failure of conventional repair or valve replacement in patients with dysplastic valves.

Key Words: Atrioventricular septal defect • Left atrioventricular valve • Mitral valve repair • Reoperation


    1. Introduction
 Top
 Abstract
 1. Introduction
 2. Patients and methods...
 3. Results
 4. Discussion
 Appendix A. Conference...
 References
 
Long-term results of atrioventricular septal defect (AVSD) repair are well documented. Reoperation following AVSD repair is most frequently for left atrioventricular valve regurgitation (LAVVR) and/or stenosis with rates reported in contemporary studies ranging from 3 to 18% for partial AVSD [14] and for complete AVSD from 6 to 14% [48].

Sparse data are available on the outcome following reintervention for LAVVR [912]. The frequency of repair versus valve replacement at reoperation is unknown. Prosthetic replacement of the LAVV should be avoided in young children and especially in infants, because of poor survival, high incidence of valve-related complications and the need for multiple subsequent valve replacements as the child grows [13,14].

We believe that when there is adequate valve leaflet tissue, reoperation can be successfully accomplished by closing the cleft and narrowing the annulus. However, if the leaflets are dysplastic, valve repair at reoperation is prone to failure. There may be too much tension to allow cleft closure and an annuloplasty may have to be so extensive that it causes stenosis [9,10,12,15].

We propose a novel repair for patients with AVSD and dysplastic leaflets. Its use may avoid failure of conventional repair and/or need for valve replacement.


    2. Patients and methods
 Top
 Abstract
 1. Introduction
 2. Patients and methods...
 3. Results
 4. Discussion
 Appendix A. Conference...
 References
 
Clinical data of all 76 patients who underwent reoperations for LAVVR performed at the Hospital for Sick Children, Toronto (HSC) and the Toronto Congenital Cardiac Centre for Adults (TCCCA) between July 1982 and December 1998 were reviewed. Indication for reintervention was moderate or severe LAVVR with (n=3, 4%) or without associated stenosis (mean Doppler gradient>5 mmHg) and signs of progressive heart failure. Included were all patients with normal ventriculo-arterial connections who underwent a biventricular repair of a complete (n=44, 58%) or a partial (n=32, 32%) AVSD.

2.1. Estimation of prevalence of reoperation for LAVVR
To estimate the prevalence of reoperation for LAVVR after AVSD repair, we reviewed the clinical data of 761 patients (partial AVSD (n=240, 31.5%) and complete AVSD (n=521, 68.5%)) who underwent AVSD repair at the Hospital for Sick Children, Toronto or the Toronto Congenital Cardiac Centre for Adults between July 1982 and December 1998. Patients whose initial repair was performed prior to 1982 or at other centers are excluded for this part of the analysis. There were 64 early deaths (8.4%). Seven (2.9%) deaths occurred after repair of a partial AVSD (six of seven were less than 1 year old) and 57 (10.9%) after repair of a complete AVSD. The mean follow-up of hospital survivors is 5.3 years (range 0–18 years, median 4.2 years). Follow-up is available on 44% of the patients beyond 5 years after repair and 77% have been seen since January 1, 1997. The prevalence of the reoperation for LAVV was analyzed by the Kaplan–Meier method.

2.2. Patient demographics and operative techniques
Three different operative techniques were utilized at reoperation for LAVVR: (1) conventional repair, consisting essentially of closing a residual cleft with or without a De Vega type annuloplasty, (2) valve replacement, or (3) patch augmentation of the superior and inferior bridging leaflets. The demographic features of the three groups of patients are outlined in Table 1.


View this table:
[in this window]
[in a new window]
 
Table 1. Patient demographicsa

 
All reoperations were performed with standard cardiopulmonary bypass, bicaval cannulation, mild to moderate hypothermia (28–34°C) and intermittent antegrade blood cardioplegic arrest. Deep hypothermic circulatory arrest was used in four patients at the beginning of the experience.

2.3. Group 1: conventional repair
Conventional repair of the LAVVR was performed in 54 patients. Although they appear younger (median age of 3 years (1 month to 38.4 years; mean 5.3±6.8 years)) than the other two groups of patients, the difference is not statistically significant. Eleven infants aged less than 1 year (20%) are counted in this group. Thirty-five patients have complete AVSD, and the remaining 19 partial AVSD, including three transitional type (AVSD with a restrictive VSD and fusion of the anterior and posterior bridging leaflets above the ventricular septum, thus dividing the common AVV into distinct left and right components). A parachute LAVV was noted in five patients and double orifice in three patients. The initial AVSD repair had been performed a median of 16 months (range 1–27 years, mean 3±5 years) beforehand. Postoperative echocardiographic data following the initial repair of the AVSD was available for 38 of the 54 patients among whom 17 (45%) had moderate to severe LAVVR and the remainder minimal incompetence.

At reoperation, in addition to closing the cleft and annuloplasty, leaflet perforation or leaflet dehiscence was sutured in 12 patients (22%), chordae were shortened in four (7.4%), papillary muscles were split in three (6%) and a commissurotomy performed in one patient. Concomitant procedures (n=13, 25%) included the closure of a residual atrial septal defect in four (7.4%) and a ventricular septal defect in four (7.4%) patients, right atrioventricular valve repair in three (6%) and a pulmonary valvotomy in two patients (4%) with associated tetralogy of Fallot.

2.4. Group 2: valve replacement
Valve replacement was performed in 14 patients (19%). They were the eldest of the three groups of patients with a median age of 11.3 years (0.9–51.4 years; mean 16.2±15.5 years), although their age is not statistically different from the other groups. Partial AVSD was present in ten patients (71.4%) and the remaining four (29%) had complete AVSD, all Rastelli type A. Two patients had a parachute LAVV, and one a double orifice. The interval between the initial repair and reoperation for LAVVR was a median of 5.5 years (4.3–35 years; mean 8.6±9.9 years) which appeared longer than the other two groups of patients, but did not reach statistical significance.

A mechanical prosthesis was implanted in 13 patients (eight Bjork–Shiley (Shiley, Inc., Irvine, CA), four St. Jude (St. Jude Medical, Inc., St. Paul, MN) and one CarboMedics (Sulzer Medica, Austin, TX) valves). Valve size ranged from 16 to 33 mm. An inverted 16-mm aortic homograft was implanted in one child. The subvalvular apparatus was partially preserved in four patients (29%). Concomitant procedures included a residual ASD closure in two patients, and a subaortic resection in one.

2.5. Group 3: patch repair
Eight patients (11%) underwent a novel patch repair illustrated in Fig. 2). The leaflet augmentation technique consists of detaching the bridging leaflets radially 2 mm from the annulus from within 2 mm of one commissure to the other (Fig. 1) . Abnormal chordal attachments to the ventricular side of the leaflet are resected to mobilize the valve tissue. A crescent-shaped patch of glutaraldehyde-treated autologous pericardium is sutured in place to augment the leaflet surface. The pericardial patch is prepared by suspending it using silk sutures at its four corners, wrapping it in a sponge, placing it in a solution of 0.625% glutaraldehyde for 5 min, then rinsing it in 100% dehydrated alcohol for 30 s and storing it in 0.9% sodium chloride solution until it is used. The augmented leaflet area allows for better leaflet coaptation and a tension-free closure of the cleft, further improving competency. An annuloplasty was performed in three of the eight patients.



View larger version (22K):
[in this window]
[in a new window]
 
Fig. 2. Freedom from reoperation for LAVVR among 761 patients who underwent AVSD repair at our center between June 1982 and December 1998. Twenty of the 240 (8%) patients with partial AVSD (dotted line) and 45 (9%) of those with complete AVSD (solid line) have undergone reoperation.

 


View larger version (63K):
[in this window]
[in a new window]
 
Fig. 1. Leaflet augmentation technique using glutaraldehyde-treated autologous pericardium for severely dysplastic left atrioventricular valves. (A) A radial incision (dotted line) is made 2 mm from the annulus in the superior and inferior bridging leaflets from commissure to commissure. (B) Abnormal chordal attachments to the ventricular side of the leaflet are resected. (C) A crescent-shaped patch of autologous glutaraldehyde-treated pericardium is sutured into the surgically created defect in the leaflet tissue. The addition of the pericardial patch allows tension-free closure of the cleft. An annuloplasty is generally required.

 
The median age at reoperation in this group is 4.5 years (range 0.2–24 years, mean 4.8±8 years). Six patients had a partial AVSD and two complete AVSD (one Rastelli type A, one type C) including one patient with a double-orifice valve. All patients were symptomatic, three in NYHA functional class III and IV. The echocardiography preoperatively had identified severe dysplasia. Moderate LAVVR was present in three patients and severe LAVVR in five. Additional procedures performed included a subaortic enlargement in two patients.

2.6. Follow-up interval
Follow-up information is available for all but five operative survivors for a follow-up rate of 93%. The mean follow-up is 4±5 years (1 month to 24 years, median 3 years); 3.9 years (1–23.9 years, median 2.4) for conventional repair, 5.2 years (0.1–15.5 years, median 3.8) for mitral valve replacement, and 2.3 years (0.2–8.5 years, median 1.0) for patch repair.

2.7. Mechanisms for LAVVR
We attempted to determine which patients failed conventional repair or underwent valve replacement and might have benefited from a patch repair. Clinical and echocardiographic data of the 68 patients who underwent a conventional repair or a valve replacement were analyzed. The patients were divided into two populations. Group 1: valve replacement or ‘failed conventional repair’ (n=23, 34%) included the postoperative cardiac deaths, and patients with residual LAVV disease necessitating early replacement (<1 year) following a conventional repair; and group 2: ‘successful repairs’ (n=45, 64%). A univariate analysis was performed using the variables listed in Table 4.


View this table:
[in this window]
[in a new window]
 
Table 4. Determinants of a successful conventional repair

 
2.8. Data acquisition and analysis
The clinical data, surgical approach, results and follow-up information was obtained from the HSC database and hospital records. Statistical analysis was performed with SPSS 8.0 (SPSS, Inc., Chicago, IL) and SAS software (SAS Institute, Cary, NC). Data are presented as median and corresponding range or mean±standard deviation. Comparisons between patient groups were performed using unpaired Student's t-test for continuous variables and {chi}2 for categorical variables. Cumulative reintervention rate over time and survival were calculated by the Kaplan–Meier method and compared using log rank test. A P value less than 0.05 was considered as statistically significant.


    3. Results
 Top
 Abstract
 1. Introduction
 2. Patients and methods...
 3. Results
 4. Discussion
 Appendix A. Conference...
 References
 
3.1. Prevalence of LAVVR following primary AVSD repair
To date, of the 761 patients whose initial repair of AVSD repair was in our center, a total of 112 patients (14.7%) have undergone reoperation. LAVVR is the most common indication for reoperation, required in 65 patients (58%) with either partial (n=20, 31%) or complete AVSD (n=45, 69%). The remaining 11 patients of the total group of 76 undergoing reoperation for LAVVR had their initial AVSD repair at another institution. Other indications for reoperation are left ventricular outflow tract obstruction (n=18, 16%) or a number of miscellaneous lesions in 29 (26%) patients (ten permanent pacemaker implantations, five pulmonary valve replacements, five VSD closures, four ASD repairs, one coronary artery bypass, four sternal wound debridement).

The LAVV repair was the only procedure in 47 patients (72%) and was associated with a concomitant surgical repair in the remaining 18 patients (28%).

The overall 10-year freedom from reoperation for LAVVR following AVSD repair is 86%. The 10-year freedom from reoperation for LAVVR was marginally better (P=0.053) in patients with partial AVSD with a rate of 89 vs. 83% in patients with a complete AVSD (Fig. 2) .

3.2. Operative mortality at reintervention for LAVVR
Among the 76 patients (65 from our center and 11 referred from elsewhere) who have undergone reoperation for LAVVR, there are six operative deaths: five following a conventional repair (9%), one after a valve replacement (7%) and none after a leaflet augmentation procedure. The operative results are outlined in Table 2. The cause of death was heart failure in all six, in combination with sepsis in two (mediastinitis, endocarditis). Four of the six deaths were in infants aged less than 1 year, who had an initial AVSD repair 1 week to 4 months prior to reoperation for severe LAVVR and progressive heart failure. The only death after LAVV replacement occurred in a child aged 10 months with a double orifice and parachute LAVV in whom an inverted aortic allograft was implanted. She developed significant prosthetic stenosis and died of mediastinitis and congestive heart failure 10 days postoperatively.


View this table:
[in this window]
[in a new window]
 
Table 2. Operative results of reintervention for LAVVRa

 
Operative mortality appeared to be influenced by age at reoperation and the interval between the initial AVSD repair and reintervention for LAVVR. The operative mortality of patients less than 1 year old is 30% (4/13), versus 3.2% (2/63) for patients older than 1 year (P=0.002). Early reintervention (less than 8 weeks) was associated with a higher operative mortality (23 vs. 4.8%, P=0.01).

3.3. Operative morbidity
One third of the patients had postoperative complications. The prevalence of complications was not different among the three groups (Table 3). Five patients required pacemaker implantation for complete atrioventricular block after reintervention; four (31%) after LAVV replacement, one (2%) after conventional repair and none after patch augmentation.


View this table:
[in this window]
[in a new window]
 
Table 3. Postoperative complications

 
3.4. Late survival
There are five late deaths (7.1%), three following a conventional repair (6.1%; two sudden death and one heart failure) and two after valve replacement (15.4%, one at reoperation and one sudden death). The 5-year survival rate is 80, 77 and 100% for conventional repair, valve replacement and patch repair groups, respectively. Long-term survival is, to date, not significantly influenced by the type of repair (P=0.50).

3.5. Subsequent reintervention
Nine patients underwent further reintervention after conventional repair at a median interval of 12 months (1 month to 12.8 years, mean 3±2.5 years). A valve replacement was performed in seven patients and two had a rerepair, after which one patient required a prosthetic valve implantation 1 year later for persistent LAVVR.

In the valve replacement group, two patients were reoperated for paravalvular leak/recall at 9 years in one patient and for outgrowth of the prosthesis at 14 years.

Amongst the eight patients who underwent a patch repair, two required further surgery and were successfully rerepaired. One of these patients was rerepaired at 5 years for subaortic stenosis and moderate LAVVR. The other patient was rerepaired at 41 months for severe LAVVR. At reoperation, the pericardial patches had not retracted, were compliant, and had not calcified. Annular dilation was responsible for the regurgitation and was corrected with an annuloplasty. Replacement of the valve was not required.

The 5-year freedom from reintervention is comparable for the three techniques (P=0.92), estimated at 81, 82 and 50% for conventional repair, valve replacement and patch repair, respectively (Fig. 3) .



View larger version (23K):
[in this window]
[in a new window]
 
Fig. 3. Freedom from subsequent reintervention following reoperation for left LAVVR. Overall, 73% are free of reoperation at 6 years after their second operation. There is no statistically important difference in freedom from second operation for the three types of operative technique; patch repair (two of eight), conventional repair (five of 54) or valve replacement (two of 14). LAVVR, left atrioventricular valve regurgitation; N, number of patients at risk at each interval; % free, a percentage of patients free from further reoperation; SE, standard error as a percentage.

 
3.6. Clinical status
At recent follow-up, surviving patients from all three groups are in NYHA functional class I or II. Supraventricular arrhythmias requiring treatment occurred in three patients, all of whom had undergone a conventional repair. One of these three patients required a permanent pacemaker for sick sinus syndrome. Following a valve replacement, two patients had a major thromboembolic episode and one patient a cerebral hemorrhage.

3.7. Echocardiographic assessment
Late echocardiographic follow-up is available for 55 (85%) survivors. Among the conventional repair patients, mild LAVVR was present in 85% and moderate LAVVR in 15%.

All eight of the patch-repair patients had echocardiographic evaluations with six patients showing mild LAVVR and two with moderate LAVVR. Mild LAVV stenosis (mean Doppler gradient=4 mmHg) was present in only one patient. None of the patients have systolic anterior motion (SAM) or left ventricular outflow tract obstruction. All of the patients with a patch augmentation repair have preserved left ventricular function.

Eighteen survivors of a valve replacement with long-term echocardiographic follow-up showed normally functioning prostheses although one patient has a 3-mm paravalvular leak. The cardiac function is mildly depressed in all valve replacement patients.

3.8. Mechanisms of LAVVR
All of the patients with a successful repair had mild to moderate dysplasia as described intraoperatively. The mechanism of LAVVR was primarily due to cleft incompetence and/or annular dilation. The presence of a parachute or double-orifice mitral valve, type of AVSD (partial or complete) and age at reoperation did not influence significantly the outcome of the repair.

At reoperation, 34% of the patients had a subsequent valve failure or required a valve replacement (Table 4). All of the patients who failed conventional surgery had severely dysplastic valves. We believe that the novel patch repair technique would have avoided a failure or valve replacement in some of these patients.


    4. Discussion
 Top
 Abstract
 1. Introduction
 2. Patients and methods...
 3. Results
 4. Discussion
 Appendix A. Conference...
 References
 
LAVVR remains an important cause of postoperative morbidity and mortality following AVSD repair despite repair techniques developed from a better understanding of the morphologic and functional features of AVSD. It remains the most frequent indication for reoperation after AVSD repair [1,2,5,7,8,12] and accounted for 56% of the reoperations in our cohort study. A number of factors have been identified as risk factor for reintervention for LAVV. A multivariate analysis of our partial AVSD repair results revealed that age less than 1 year and the presence of moderate to severe LAVVR before AVSD repair were predictive of reoperation for LAVVR [1]. Following complete AVSD repair, the presence of a double-orifice LAVV was the only significant predictor of reoperation by multivariate analysis [5].

Improvements in echocardiographic evaluation and an increasing clinical experience with this pathology have helped to identify mechanisms of regurgitation. The pathophysiology of LAVVR appears to be multifactorial. Abnormalities of one or more of the atrioventricular valve components, the annulus, leaflets, chordae or the papillary muscles, can contribute to incompetence. Cleft incompetence is the most frequent finding. Other valvular abnormalities have been observed in our patient population and also reported by other authors including isolated annular dilation, chordal abnormalities, parachute valve and double-orifice valve [9,10,12,15]. LAVV dysplasia has been identified as a potential deterrent to a successful repair [9,10,15]. Acar et al. [16] demonstrated that a relative decrease in leaflet surface area, as calculated by three-dimensional echocardiography, could be responsible for regurgitation at the level of the cleft and also at the commissures.

Cleft incompetence, annular dilation and lesser degree of dysplasia appear to lend themselves to a successful conventional repair consisting of a cleft closure with or without an annuloplasty [9,10].

Because of the wide spectrum of lesions, multiple techniques of valve repair may be needed including modifications of those used in adults. The use of a pericardial patch augmentation has been previously described by the Carpentier group, primarily for mural leaflet enlargement in degenerative mitral disease and in the treatment of endocarditis [17]. They studied the performance of the autologous pericardial patches fixed in glutaraldehyde in a series of 64 patients followed over a 3-year period. Repeat echocardiographic studies revealed preserved pericardial tissue with normal compliance and without evidence of calcification. These satisfactory results have also been noted in children in spite of the known propensity for younger patients to prosthetic calcification. In two of our patients, at reoperation the pericardial patches were free of signs of deterioration and permitted a successful rerepair. In contrast, valve replacement was required in six of seven patients who required reoperation after a conventional repair. Durability of the patch augmentation is demonstrated by the first child in the series who continues to do well 8.5 years after repair.

Our results confirm findings of the few published series of reoperations for LAVVR after AVSD repair. Alexi-Meskishvili et al. reported the experience of the German Heart Institute in 28 patients [9]. Cleft closure combined with an annuloplasty in addition to other valve repair procedures resulted in the successful decreased LAVVR in 64% (n=18) of their patients. In five, severe LAVVR led to valve replacement. Anomalies other than cleft incompetence were predictive of recurrent severe postoperative LAVVR.

Lamberti et al. [11] reported reoperations in 14 patients who had prior AVSD repair, among whom four required valve replacement (30%). At the mean follow-up of 3 years, all ten of the repaired patients had no or mild LAVVR on echocardiographic evaluation.

Repair offers the advantage of avoiding the need for lifelong anticoagulation in children and the absence of thromboembolic complications. Following valve replacement, mortality rate in infants is especially high [14,18]. The survival was estimated at 52% at 1 year and 43% at 5 years by Koboda et al. from the Children's Hospital in Boston [14]. The survival was over 80% at 10 years in our population of patients who appeared to be slightly older.

In conclusion, there are multiple mechanisms of LAVVR after repair of an AVSD. In our experience, reoperation has been required in 14% of patients within 10 years of an AVSD repair. When these patients have adequate leaflet tissue, conventional repair may produce a satisfactory long-term outcome. However, when the LAVV leaflets are dysplastic, as they were in 34% of our patients, leaflet augmentation with autologous pericardium may lessen the risk of a failed valve repair and/or the need for valve replacement. A pericardial patch repair can be safely be performed and is durable.


    Acknowledgments
 
We would like to thank Mr Jay Joseph BA MSc, CHSS Data Manager, for his statistical advice and Mrs Gail Williams for data management. This work was made possible through a grant from La Fondation de Recherche en Santé du Quebec.


    Footnotes
 
Presented at the 13th Annual Meeting of the European Association for Cardio-thoracic Surgery, Glasgow, Scotland, UK, September 5–8, 1999.


    Appendix A. Conference discussion
 Top
 Abstract
 1. Introduction
 2. Patients and methods...
 3. Results
 4. Discussion
 Appendix A. Conference...
 References
 
Dr C. Brizard (Victoria, Australia): In Melbourne, we have a similar approach of the understanding of the regurgitation and the way to treat it. However, we don't call the valve a dysplastic valve. We believe that the thickening of the valve is secondary to the regurgitation itself. And my question is twofold. Do you think that what you call the dysplastic valve is indeed secondary to the regurgitation? And if you do, in the view of your result, do you think that you should have earlier reoperation? Are you going to ask your cardiologist to bring the patient to you earlier and reoperate on more patients?

Dr Poirier: Adult patients who undergo reoperation for left atrioventricular valve regurgitation do appear to have more valvular dysplasia, leaflet tissue retraction and thickening than in infants and children. We believe that with time the valves do become more dysplastic, particularly patients that had thickened leaflets and abnormal subvalvular apparatus at initial AVSD repair. The left atrioventricular valve has a complex anatomy and multiple mechanisms of regurgitation. Valve repair is not always successful and early or late valve replacement is a definite possibility. If we can guarantee repairability then we can be more aggressive and repair earlier, possibly avoiding an increase in dysplasia that renders a later repair difficult and preserving left ventricular systolic function. Otherwise a more conservative approach is appropriate.

Dr D. DiCarlo (Rome, Italy): Your technique makes a lot of sense and was very nicely presented. You state in your presentation and in your abstract that it allows for a tension-free closure of the cleft, which is obviously a major problem, and very often we find that regurgitation is due to the fact that sutures have cut across the cleft margins. I don't know if this was the case, but in your slide the way that the mitral valve was shaped showed a very small posterior leaflet, which is usually considered in the literature, whether under one-third of the circumference or not, a contraindication for closure of the cleft. So I was wondering whether it was just a case that the drawing was done this way, or whether you implied that in that particular case the cleft has to be closed at any price? That's my first question. Please also comment on your techniques of closing the cleft because we seem to continue to have a lot of dehiscence nowadays.

Dr Poirier: The illustration in not quite to scale. Left atrioventricular valves post-AVSD repair with small posterior leaflets are essentially monoleaflet valves that can benefit from the enlargement of the bridging leaflets or of the posterior leaflet, using our technique. The cleft is completely closed whenever possible unless this induces stenosis, at which time the cleft is only partially closed. Interrupted stitches using monofilament or braided suture material is used.


    References
 Top
 Abstract
 1. Introduction
 2. Patients and methods...
 3. Results
 4. Discussion
 Appendix A. Conference...
 References
 

  1. Najm H.K., Williams W.G., Chuaratanaphong S., Watzka S.B., Coles J.G., Freedom R.M. Primum atrial septal defect in children: early results, risk factors and freedom from reoperation. Ann Thorac Surg 1998;66:829-835.[Abstract/Free Full Text]
  2. Gatzoulis M.A., Hachter S., Webb G.D., William W.G. Surgery for partial atrioventricular septal defect in the adult. Ann Thorac Surg 1999;67:504-510.[Abstract/Free Full Text]
  3. Sadeghi A.M., Laks H., Pearl J.M. Primum atrial septal defect. Semin Thorac Cardiovasc Surg 1997;9:2-7.[Medline]
  4. Permut L.C., Mehta V. Late results and reoperation after repair of complete and partial atrioventricular canal defect. Semin Thorac Cardiovasc Surg 1997;9:44-54.[Medline]
  5. Najm H.K., Coles J.G., Endo M., Stephens D., Rebeyka I.M., Williams W.G., Freedom R.M. Complete atrioventricular septal defects. Results of repair, risk factors and freedom from reoperation. Circulation 1997;96(Suppl II):II311-II315.
  6. Tweddell J.S., Litwin S.B., Berger S., Friedberg D.Z., Thomas J.P., Frommelt P.C., Frommelt M.A., Pelech A.N., Lewis D.A., Fedderly R.T., Mussatto K.A., Kessel M.W. Twenty-year experience with repair of complete atrioventricular septal defect. Ann Thorac Surg 1996;62:419-424.[Abstract/Free Full Text]
  7. Hanley F.L., Fenton K.N., Jonas R.A., Mayer J.E., Cook N.R., Wernovsky G., Casteneda A. Surgical repair of complete atrioventricular canal defects in infancy. J Thorac Cardiovasc Surg 1993;106:387-397.[Abstract]
  8. Bando K., Turrentine M.W., Sun K., Sharp T.G., Ensing G.J., Miller A.P., Kesler K.A., Binford R.S., Carlos G.N., Hurwitz R.A. Surgical management of complete atrioventricular septal defect: a twenty-year experience. J Thorac Cardiovasc Surg 1995;110:1543-1554.[Abstract/Free Full Text]
  9. Alexi-Meskishvili V., Hertzer R., Dahnert I., Weng Y., Lange P.E. Results of left atrioventricular valve reconstruction after previous correction of atrioventricular septal defects. Eur J Cardio-thorac Surg 1997;12:460-465.[Abstract]
  10. Abbruzzese P.A., Napoleone A., Bini R.M., Annechino F.P., Merlo M., Parenzan L. Late left atrioventricular valve insufficiency after repair of partial atrioventricular septal defects: anatomical and surgical determinants. Ann Thorac Surg 1990;49:111-114.[Abstract]
  11. Lamberti J.L., Jenson T.S., Grehl T.M., Oury J.H., Wladman J.D., Kirkpatrick S.E., George L., Mathewson J.W., Spicer R.L. Late reoperation for systemic atrioventricular valve regurgitation after repair of congenital heart defects. Ann Thorac Surg 1989;47:517-523.[Abstract]
  12. Aharon A.S., Laks H., Drinkwater D.C., Chugh R., Gates R.N., Grant P.W., Permut L.C., Ardehali A., Rudis E. Early and late results of mitral valve repair in children. J Thorac Cardiovasc Surg 1994;107:1262-1271.[Abstract/Free Full Text]
  13. Williams W.G., Pollack J.C., Geiss D.M., Trusler G.A., Fowler R.S. Experience with aortic and mitral valve replacement in children. J Thorac Cardiovasc Surg 1981;81:326-333.[Abstract]
  14. Kadoba K., Jonas R.A., Mayer J.E., Castenada A.R. Mitral valve replacement in the first year of life. J Thorac Cardiovasc Surg 1984;25:537-544.
  15. Losay J., Rosenthal A., Castaneda A.R., Bernhard W.H., Nadas A.S. Repair of atrial septal deficit primum results, course and prognosis. J Thorac Cardiovasc Surg 1978;75:248-254.[Abstract]
  16. Acar P., Laskari C., Rhodes J., Pandian N., Warner K., Marx G. Three-dimensional echocardiography analysis of valve anatomy as a determinant of mitral regurgitation after surgery for atrioventricular septal defects. Am J Cardiol 1999;83:745-749.[Medline]
  17. Chauvaud S., Jebara J., Chachques J.C., el Asmar B., Mihaileanu S., Perier P., Dreyfus G., Relland J., Couetil J.P., Carpentier A. Valve extension with glutaraldehyde preserved autologous pericardium: results in mitral valve repair. J Thorac Surg 1991;102:171-178.[Abstract]
  18. Williams W.G., Pollack J.C., Geiss D.M., Trusler G.A., Fowler R.S. Experience with aortic and mitral valve replacement in children. J Thorac Cardiovasc Surg 1981;81:326-333.



This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
S. P. Malhotra, F. Lacour-Gayet, M. B. Mitchell, D. R. Clarke, M. L. Dines, and D. N. Campbell
Reoperation for left atrioventricular valve regurgitation after atrioventricular septal defect repair.
Ann. Thorac. Surg., July 1, 2008; 86(1): 147 - 152.
[Abstract] [Full Text] [PDF]


Home page
Card Surg AdultHome page
H. Laks, D. Marelli, M. Plunkett, and J. Myers
Adult Congenital Heart Disease
Card. Surg. Adult, January 1, 2008; 3(2008): 1431 - 1464.
[Full Text]


Home page
Ann. Thorac. Surg.Home page
Y.-Q. Lai, Y. Luo, C. Zhang, and Z.-G. Zhang
Utilization of Double-Orifice Valve Plasty in Correction of Atrioventricular Septal Defect
Ann. Thorac. Surg., April 1, 2006; 81(4): 1450 - 1454.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
C. Barrea, S. Levasseur, K. Roman, M. Nii, J. G. Coles, W. G. Williams, and J. F. Smallhorn
Three-dimensional echocardiography improves the understanding of left atrioventricular valve morphology and function in atrioventricular septal defects undergoing patch augmentation
J. Thorac. Cardiovasc. Surg., April 1, 2005; 129(4): 746 - 753.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
W. G. Williams, C. van der Lee, L. A. van Herwerden, W. B. Vletter, F. J. ten Cate, and M. J.M. Kofflard
Combined Anterior Mitral Leaflet Extension and Myectomy in Hypertrophic Obstructive Cardiomyopathy * Response
Circulation, June 29, 2004; 109(25): e324 - e324.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
E. Prifti, M. Bonacchi, M. Bernabei, A. Crucean, B. Murzi, F. Bartolozzi, V. S. Luisi, M. Leacche, N. S. Nathan, and V. Vanini
Repair of complete atrioventricular septal defects in patients weighing less than 5 kg
Ann. Thorac. Surg., May 1, 2004; 77(5): 1717 - 1726.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
B. K. Eble, W. P. Fiser, P. Simpson, J. Dugan, J. J. Drummond-Webb, and A. T. Yetman
Mitral valve replacement in children: predictors of long-term outcome
Ann. Thorac. Surg., September 1, 2003; 76(3): 853 - 859.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
E. Prifti, M. Bonacchi, M. Leacche, and V. Vanini
A modified 'single patch' technique for complete atrioventricular septal defect correction
Eur. J. Cardiothorac. Surg., July 1, 2002; 22(1): 151 - 153.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. Sittiwangkul, R. Y. Ma, B. W. McCrindle, J. G. Coles, and J. F. Smallhorn
Echocardiographic assessment of obstructive lesions in atrioventricular septal defects
J. Am. Coll. Cardiol., July 1, 2001; 38(1): 253 - 261.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Nancy C. Poirier
Glen S. Van Arsdell
John G. Coles
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Poirier, N. C.
Right arrow Articles by Freedom, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Poirier, N. C.
Right arrow Articles by Freedom, R. M.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS